Related Experiment Videos
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer
A R Genazzani1, A Gadducci, M Gambacciani
1Department of Reproductive Medicine and Child Development, Division of Gynecology and Obstetrics, University of Pisa, Via Roma 35, 56126, Pisa, Italy. a.genazzani@obgyn.unipi.it
Maturitas
|November 22, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Particle Beam Re-irradiation in Oligo Recurrent Gynecological Malignancies.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy?
European journal of gynaecological oncology·2016
Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality.
Journal of clinical neurology (Seoul, Korea)·2026
PRMT7-mediated arginine methylation of FOXK activates Wnt/β-catenin signalling to drive doxorubicin resistance in diffuse large B-cell lymphoma.
Clinical and translational medicine·2026
The neuro-immune-vascular landscape of lung cancer brain metastasis: insights from organoid models.
Frontiers in immunology·2026